A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Recruiting · NCT05329103 · Registry updated 2026-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors | Advanced Solid Tumor | Recruiting | Phase 1 | 2026-05-15 | NCT05329103 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Peel Therapeutics Inc | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Abramson Cancer Center at Pennsylvania Hospital | Philadelphia | United States | 3 |
| Carolina BioOncology Institute | Huntersville | United States | 22 |
| HonorHealth Research Institiute | Scottsdale | United States | 1 |
| Huntsman Cancer Institute, University of Utah | Salt Lake City | United States | 45 |
| Mary Crowley Cancer Research | Dallas | United States | 29 |
| NEXT Virginia | Fairfax | United States | 83 |
| Rhode Island Hospital | Providence | United States | 229 |
| Stanford Cancer Center | Palo Alto | United States | 11 |